Matches in Wikidata for { <http://www.wikidata.org/entity/Q88608753> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q88608753 description "artículu científicu espublizáu en xunetu de 2017" @default.
- Q88608753 description "scientific article published on 26 July 2017" @default.
- Q88608753 description "wetenschappelijk artikel" @default.
- Q88608753 description "наукова стаття, опублікована в липні 2017" @default.
- Q88608753 name "CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention" @default.
- Q88608753 name "CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention" @default.
- Q88608753 type Item @default.
- Q88608753 label "CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention" @default.
- Q88608753 label "CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention" @default.
- Q88608753 prefLabel "CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention" @default.
- Q88608753 prefLabel "CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention" @default.
- Q88608753 P1433 Q88608753-9861F234-BF2E-4331-A50A-2936D5374750 @default.
- Q88608753 P1476 Q88608753-759F3CBD-E616-4742-ABBB-D16EE47F9082 @default.
- Q88608753 P2093 Q88608753-1EBE0193-FAC2-483C-BECB-D04E4050739D @default.
- Q88608753 P2093 Q88608753-51CD48DA-4547-4194-B646-AB1FE56F44AC @default.
- Q88608753 P2093 Q88608753-6F1F1440-72CF-4F32-80EF-B503BC8CE563 @default.
- Q88608753 P2093 Q88608753-A2AC3265-8ACB-4C29-8168-CB6D56A910E4 @default.
- Q88608753 P2093 Q88608753-B908AB55-97A0-4214-9C23-FBE0E8071C24 @default.
- Q88608753 P304 Q88608753-5C305711-FC5C-49C7-BF34-408CA6708EB2 @default.
- Q88608753 P31 Q88608753-F3B6FBE7-BA3C-46F9-8020-7377B0AC5289 @default.
- Q88608753 P356 Q88608753-BB88C91A-12DA-41D6-84C6-612DEC5857E6 @default.
- Q88608753 P433 Q88608753-B587BE17-8C02-4333-BA5E-253B6C1C3B82 @default.
- Q88608753 P478 Q88608753-D96CC540-562E-48E1-978E-A7BA38EDEE1A @default.
- Q88608753 P50 Q88608753-4C41C44A-A55C-4141-8F6D-195034A1AB2D @default.
- Q88608753 P577 Q88608753-5AEE20BC-13BC-45BF-9757-B594A7CB4AEA @default.
- Q88608753 P698 Q88608753-582A1BA0-FE19-427F-B637-9671BDE59303 @default.
- Q88608753 P356 PGS-2017-0075 @default.
- Q88608753 P698 28745582 @default.
- Q88608753 P1433 Q15724625 @default.
- Q88608753 P1476 "CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention" @default.
- Q88608753 P2093 "George A Stouffer" @default.
- Q88608753 P2093 "Joel F Farley" @default.
- Q88608753 P2093 "Melissa J Polasek" @default.
- Q88608753 P2093 "Mrudula S Borse" @default.
- Q88608753 P2093 "Olivia M Dong" @default.
- Q88608753 P304 "1155-1166" @default.
- Q88608753 P31 Q13442814 @default.
- Q88608753 P356 "10.2217/PGS-2017-0075" @default.
- Q88608753 P433 "12" @default.
- Q88608753 P478 "18" @default.
- Q88608753 P50 Q56883997 @default.
- Q88608753 P577 "2017-07-26T00:00:00Z" @default.
- Q88608753 P698 "28745582" @default.